4.5 Article Proceedings Paper

Mast cell mediator responses and their suppression by pathogenic and commensal microorganisms

Journal

MOLECULAR IMMUNOLOGY
Volume 63, Issue 1, Pages 74-79

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.molimm.2014.02.006

Keywords

Mast cells; Degranulation; Infection; Pathogen; Commensal; Mast cell-suppression; Anti-inflammatory

Funding

  1. US National Institutes of Health [U01-AI082107, R01-AI096305, R56-DK095198]
  2. Duke-NUS, Singapore

Ask authors/readers for more resources

Mast cells (MCs) are selectively found at the host environment interface and are capable of secreting a wide array of pharmacologically active mediators, many of which are prepackaged in granules. Over the past two decades, it has become clear that these cells have the capacity to recognize a range of infectious agents allowing them to play a key role in initiating and modulating early immune responses to infectious agents. However, a number of pathogenic and commensal microbes appear to have evolved distinct mechanisms to suppress MC mediator release to avoid elimination in the host. Understanding how these microbes suppress MC functions may have significant therapeutic value to relieve inflammatory disorders mediated by MCs. (C) 2014 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Pharmacology & Pharmacy

Mast cell activators as novel immune regulators

Brandi Johnson-Weaver, Hae Woong Choi, Soman N. Abraham, Herman F. Staats

CURRENT OPINION IN PHARMACOLOGY (2018)

Article Multidisciplinary Sciences

MRGPR-mediated activation of local mast cells clears cutaneous bacterial infection and protects against reinfection

Mohammad Arifuzzaman, Yuvon R. Mobley, Hae Woong Choi, Pradeep Bist, Cristina A. Salinas, Zachary D. Brown, Swaine L. Chen, Herman F. Staats, Soman N. Abraham

SCIENCE ADVANCES (2019)

Article Biochemical Research Methods

Identification of Novel Mast Cell Activators Using Cell-Based High-Throughput Screening

Hae Woong Choi, Cliburn Chan, Ivo D. Shterev, Heather E. Lynch, Taylor J. Robinette, Brandi T. Johnson-Weaver, Jianling Shi, Gregory D. Sempowski, So Young Kim, John K. Dickson, David M. Gooden, Soman N. Abraham, Herman F. Staats

SLAS DISCOVERY (2019)

Article Cell Biology

A humanized mouse model to study mast cells mediated cutaneous adverse drug reactions

Andrea Mencarelli, Merry Gunawan, Kylie Su Mei Yong, Pradeep Bist, Wilson Wei Sheng Tan, Sue Yee Tan, Min Liu, Edwin Kunxiang Huang, Yong Fan, Jerry Kok Yen Chan, Hae Woong Choi, Soman N. Abraham, Qingfeng Chen

JOURNAL OF LEUKOCYTE BIOLOGY (2020)

Article Immunology

Novel mucosal adjuvant, mastoparan-7, improves cocaine vaccine efficacy

Ashley L. St John, Hae Woong Choi, Q. David Walker, Bruce Blough, Cynthia M. Kuhn, Soman N. Abraham, Herman F. Staats

NPJ VACCINES (2020)

Article Immunology

A highly polarized TH2 bladder response to infection promotes epithelial repair at the expense of preventing new infections

Jianxuan Wu, Byron W. Hayes, Cassandra Phoenix, Gustavo Sosa Macias, Yuxuan Miao, Hae Woong Choi, Francis M. Hughes, J. Todd Purves, R. Lee Reinhardt, Soman N. Abraham

NATURE IMMUNOLOGY (2020)

Article Multidisciplinary Sciences

Platelets trigger perivascular mast cell degranulation to cause inflammatory responses and tissue injury

Jorn Karhausen, Hae Woong Choi, Krishna Rao Maddipati, Joseph P. Mathew, Qing Ma, Yacine Boulaftali, Robert Hugh Lee, Wolfgang Bergmeier, Soman N. Abraham

SCIENCE ADVANCES (2020)

Article Immunology

Nasal Immunization With Small Molecule Mast Cell Activators Enhance Immunity to Co-Administered Subunit Immunogens

Brandi T. Johnson-Weaver, Hae Woong Choi, Hang Yang, Josh A. Granek, Cliburn Chan, Soman N. Abraham, Herman F. Staats

Summary: Through high-throughput screening, three novel small molecule mast cell activators were identified, which showed efficacy comparable to traditional mast cell activators and provided similar levels of protective immune responses in nasal vaccines.

FRONTIERS IN IMMUNOLOGY (2021)

Article Biochemistry & Molecular Biology

FK506-binding protein-like and FK506-binding protein 8 regulate dual leucine zipper kinase degradation and neuronal responses to axon injury

Bohm Lee, Yeonsoo Oh, Eunhye Cho, Aaron DiAntonio, Valeria Cavalli, Jung Eun Shin, Hae Woong Choi, Yongcheol Cho

Summary: This study identified FKBPL and FKBP8 as novel interacting proteins that regulate the stability of DLK through the ubiquitin-proteasome and lysosomal protein degradation pathways.

JOURNAL OF BIOLOGICAL CHEMISTRY (2022)

Article Medicine, General & Internal

β-Defensin 2, an Antimicrobial Peptide, as a Novel Biomarker for Ulcerative Interstitial Cystitis; Can β-Defensin 2 Suspect the Dysbiosis of Urine Microbiota?

Sang Wook Lee, Si Hyun Kim, Kwang Woo Lee, Woong Bin Kim, Hae Woong Choi, Ji Eun Moon, Ahrim Moon, Young Ho Kim

Summary: The study found that the expression of BD-2 in the urine of patients with Hunner type IC was 18 times higher than in patients with non-Hunner type IC. The increased secretion of BD-2 in urine of Hunner type IC patients was strongly correlated with increased mast cell counts associated with bladder IC pathology, showing potential as a biomarker.

DIAGNOSTICS (2021)

Review Biochemistry & Molecular Biology

Tumor-Associated Mast Cells in Urothelial Bladder Cancer: Optimizing Immuno-Oncology

Hae Woong Choi, Manisha Naskar, Ho Kyung Seo, Hye Won Lee

Summary: Urothelial bladder cancer (UBC) is a common and aggressive malignancy, with the tumor microenvironment (TME) and mast cells (MCs) playing potential key roles in tumor progression and treatment. Early-stage UBC patients may have infiltration of MCs, which could impact prognosis based on tumor type and location. Immunotherapeutic methods are common in treating UBC, and understanding MC involvement may be crucial in unlocking the full potential of immunotherapy.

BIOMEDICINES (2021)

Article Biotechnology & Applied Microbiology

Enhancing adoptive T-cell therapy with fucoidan-based IL-2 delivery microcapsules

Eun Young Jeon, Da-som Choi, Seunghyun Choi, Ju-young Won, Yunju Jo, Hye-bin Kim, Youngmee Jung, Sang Chul Shin, Hophil Min, Hae Woong Choi, Myeong Sup Lee, Yoon Park, Justin J. Chung, Hyung-seung Jin

Summary: This study developed a complex coacervate to deliver IL-2 in a sustained manner and enhance the activity of immune cells within tumors. The use of this coacervate allowed for localized delivery of IL-2 and protection against the acidic tumor microenvironment.

BIOENGINEERING & TRANSLATIONAL MEDICINE (2023)

Review Medicine, General & Internal

The Urinary Microbiome: Role in Bladder Cancer and Treatment

Veronika Friedrich, Hae Woong Choi

Summary: Dysbiosis of the urinary microbiome can contribute to the development of bladder cancer by creating a chronically inflammatory urothelial microenvironment. Modulating the urinary microbiome can alter the host immune system and cytokine responses, potentially providing a therapeutic approach for bladder cancer.

DIAGNOSTICS (2022)

Article Urology & Nephrology

Microbiome in urological diseases: Axis crosstalk and bladder disorders

Hae Woong Choi, Kwang Woo Lee, Young Ho Kim

Summary: This review describes the association between the human urinary microbiome and urinary diseases, as well as its interconnection with microbiota of other organs. The microbiota of the gastrointestinal, vaginal, kidney, and bladder play a role in the development and progression of urinary diseases through dynamic bidirectional communication along the bladder-centered axis. Disturbances in the microbial communities can lead to the emergence of urinary diseases.

INVESTIGATIVE AND CLINICAL UROLOGY (2023)

Article Medicine, Research & Experimental

Necroptosis of infiltrated macrophages drives Yersinia pestis dispersal within buboes

Mohammad Arifuzzaman, W. X. Gladys Ang, Hae Woong Choi, Matthew L. Nilles, Ashley L. St John, Soman N. Abrahamn

JCI INSIGHT (2018)

No Data Available